Kymera also told investors that the French drugmaker plans to advance the therapy, KT-474, into Phase 2 clinical studies for the same conditions next year. Kymera's stock is down 59.3% year-to ...

Kymera Therapeutics, Inc. KYMR reported a first-quarter 2025 loss of 82 cents per share, narrower than the Zacks Consensus Estimate of a loss of 92 cents. In the year-ago quarter, ...

Kymera has collaborative deals with both Vertex and Sanofi, totalling some $220mn upfront. The firm was initially backed by Atlas Ventures, which is still the largest shareholder.

Shares of Kymera KYMR have surged 70.7% in the past three months compared with the industry’s gain of 9.7%. The stock has ...

Get the annual and quarterly balance sheet of Kymera Therapeutics, Inc. (KYMR) including details of assets, liabilities and shareholders' equity.

Have you had a look at all of the Kymera styles in Fortnite? Aliens have landed in Fortnite Chapter 2 Season 7, introducing the Kymera race of extraterrestrials to the battle royale game.These ...

TRANSFORMING a standard truck into an off road monster has been a passion project for one man and his team of genius ...

Kymera Therapeutics has secured $102 million as it prepares for clinical trials of oral drugs the company hopes will be better alternatives to existing injected medications for cancer and ...

When we last checked in with Jason Woods, he’d electrified his Kymera powered body board and was aiming for a 2013 release and US$5,000 retail price. To finally get the Kymera in the hands ...